The Liver Meeting® 2019

5 (4 votes)

View on-demand presentations from The Liver Meeting® 2019 in Boston. The Liver Meeting® is AASLD’s largest meeting covering a variety of trending topics. 

  • AASLD/APASL Joint Symposium: Acute on Chronic Liver Failure

    Product not yet rated Contains 3 Component(s) Recorded On: 11/10/2019

    AASLD/APASL Joint Symposium: Acute on Chronic Liver Failure presented at The Liver Meeting® 2019.

    Acute on Chronic Liver Failure (ACLF) is a well-recognized rapid course of liver disease that can have devastating consequences on patients. At this symposium, faculty will discuss ACLF’s common triggers and explore current perspectives of management in the context of these triggering events. Topics covered include microbiome analysis to identify high-risk patients and the role of transplantation.

    Shiv Kumar Sarin
    Jacqueline G. O'Leary

  • AASLD/NASPGHAN Pediatric Symposium: New Endoscopic Frontiers in Liver Disease

    Contains 5 Component(s) Recorded On: 11/08/2019

    AASLD/NASPGHAN Pediatric Symposium: New Endoscopic Frontiers in Liver Disease presented at The Liver Meeting® 2019.

    At this symposium, experts on pediatric acute liver failure (PALF) will review the role of inflammation in etiopathogenesis of common comorbidities and discuss emerging topics in pediatric acute-on-chronic liver failure and extrahepatic support strategies. They will discuss the complexity of medical decision making in PALF and review indications for liver transplant in these patients.

    Edward Behrens
    Anil Dhawan
    James E. Squires
    Janis M. Stoll

  • Acute on Chronic Liver Failure SIG & Portal Hypertension SIG: Acute and Chronic Kidney Failure in Cirrhosis: Mechanisms to Management

    Contains 7 Component(s) Recorded On: 11/08/2019

    Acute on Chronic Liver Failure SIG & Portal Hypertension SIG: Acute and Chronic Kidney Failure in Cirrhosis: Mechanisms to Management presented at The Liver Meeting® 2019.

    This two-session program explores the pathophysiology, diagnosis and treatment of kidney failure in patients with cirrhosis. The first session reviews chronic kidney manifestations of portal hypertension, including sodium retention, ascites and chronic kidney failure. The second session discusses acute kidney injury in ACLF. Each part includes a case presentation to highlight management controversies, expert panel interviews and Q&A.

    Agustin Albillos
    Guadalupe Garcia-Tsao
    Constantine J. Karvellas
    Josh Levitsky
    Puneeta Tandon
    Florence Wong

  • Advances for Practitioners: New AASLD Guidelines: Updated Recommendations and Ongoing Challenges in HCC, PBC and ALD

    Contains 4 Component(s) Recorded On: 11/11/2019

    Advances for Practitioners: New AASLD Guidelines: Updated Recommendations and Ongoing Challenges in HCC, PBC and ALD presented at The Liver Meeting® 2019.

    AASLD Guideline/Guidance Statements on treating hepatocellular carcinoma (HCC), primary biliary cholangitis (PBC) and alcohol-related liver disease (ALD) are now updated to reflect data published since 2010, when the previous versions were released. At this session, the guidelines’ authors will highlight important changes hepatologists should know and discuss controversial or challenging issues in treating patients with these chronic liver diseases.

    Julie Heimbach
    Keith D. Lindor
    Michael R. Lucey

  • Alcohol-Related Liver Diseases SIG: Emerging Therapies and Current Clinical Trials for Alcoholic Hepatitis

    Contains 5 Component(s) Recorded On: 11/10/2019

    Alcohol-Related Liver Diseases SIG: Emerging Therapies and Current Clinical Trials for Alcoholic Hepatitis presented at The Liver Meeting® 2019.

    Review data from ongoing clinical trials for alcoholic hepatitis, explore the role of early liver transplantation and discuss the management of alcohol use disorder in patients with alcoholic hepatitis and acute on chronic liver failure. Topics covered include trial design considering standards of care and liver transplantation’s emerging role and subject recruitment challenges for clinical trials in alcoholic hepatitis.

    Patrick S. Kamath
    Lorenzo Leggio
    Bernd Schnabl
    Vijay Shah

  • Career Development Workshop

    Product not yet rated Contains 8 Component(s) Recorded On: 11/08/2019

    Career Development Workshop presented at The Liver Meeting® 2019.

    The Career Development Workshop is designed for hepatologists in the early career stage. Participants will explore how to maximize career opportunities in basic and clinical research, and will discuss potential sources of research funding for each pathway. They will also review an array of career pathways in both academic and community practice, and possible rewards and challenges hepatologists may encounter.

    Kimberly Ann Brown
    Oren K. Fix
    Ayman A. Koteish
    Valentina Medici
    Sonali Paul
    Elliot B. Tapper
    Monica A. Tincopa

  • Cholestatic and Autoimmune Liver Diseases SIG: Bile Acid Signaling and Cholestatic Liver Diseases

    Product not yet rated Contains 4 Component(s) Recorded On: 11/08/2019

    Cholestatic and Autoimmune Liver Diseases SIG: Bile Acid Signaling and Cholestatic Liver Diseases presented at The Liver Meeting® 2019.

    Recent approval of the synthetic FXR agonist obeticholic acid for primary biliary cholangitis treatment shows that targeting nuclear receptors in treating liver diseases, particularly cholestatic and autoimmune conditions, has therapeutic potential.

    Saul J. Karpen
    Keith D. Lindor
    Huiping Zhou

  • Clinical Practice SIG: Controversies in Clinical Hepatology

    Product not yet rated Contains 5 Component(s) Recorded On: 11/08/2019

    Clinical Practice SIG: Controversies in Clinical Hepatology presented at The Liver Meeting® 2019.

    What are the hotly debated issues in clinical hepatology today? At this session, explore current controversies in the field, including the role of statins, optimal management of acute gastric variceal bleeding and treatment of HCV in people who inject drugs. Speakers will then propose evidence-based guidance to address these difficult or challenging issues.

    Jaime Bosch
    Patrick Grant Northup
    Shiv Kumar Sarin
    Paul J. Thuluvath

  • Clinical Research Workshop: Microbiome as a Model of Clinical Research: From Stool to Study to Treatment

    Product not yet rated Contains 4 Component(s) Recorded On: 11/08/2019

    Clinical Research Workshop: Microbiome as a Model of Clinical Research: From Stool to Study to Treatment presented at The Liver Meeting® 2019.

    The microbiome is recognized as an important player in liver disease pathogenesis. The liver’s close proximity to the gut makes it particularly susceptible to changes in the intestinal microbiome. This workshop uses the microbiome as an example to facilitate appreciation of the tools available to perform clinical research, as well as specific research tactics for microbiome-related study.

    Mamatha Bhat
    Anna Mae Diehl
    Herbert Tilg

  • NAFLD Debrief

    Contains 2 Component(s) Recorded On: 11/12/2019

    NAFLD Debrief presented at The Liver Meeting® 2019.

    Review key highlights from all the exciting clinical research presented at The Liver Meeting® 2019.

    Kathleen E. Corey